New CEO appointed of peak national body for pharmacistsBack to previous page
php echo wp_list_categories(); ?>
March 29, 2018
Mr Graham Catt has been appointed as the new Chief Executive Officer (CEO) of the peak national body for pharmacists, the Pharmaceutical Society of Australia (PSA).
As a highly experienced and influential executive, Mr Catt brings a wealth of experience to the role after working for several national membership organisations focused on healthcare over the past 15 years.
On behalf of PSA’s Board, National President Dr Shane Jackson welcomed Mr Catt’s appointment, saying: “Graham has a proven track record of leading transformation and strategic growth of national associations, including the Royal Australian College of General Practitioners (RACGP) and Australian Veterinary Association where he has worked for the past decade.
“He has achieved success by engaging with and influencing key stakeholders and Government, and significantly grown membership in his association roles.
“I am confident Graham’s strategic leadership of PSA will ensure all pharmacists are well represented, recognised and rewarded as vital healthcare practitioners.
“It’s an exciting time for PSA and the profession in Australia – and having someone of Mr Catt’s calibre to help lead the peak body for all pharmacists is a positive step for the future.”
Mr Catt said he was honoured to accept this important leadership role for PSA and Australia’s pharmacy profession.
“I am delighted to be joining an organisation with a strong strategic vision, including for membership growth, advocacy and professional development to support all pharmacists, no matter what their scope of practice,” Mr Catt said.
“I look forward to working with PSA’s members, National Board, Branch Committees, corporate partners and key stakeholders as well as other pharmacy leaders to pursue PSA’s vision of improving Australia’s health through excellence in pharmacist care.”
Mr Catt will officially start with PSA in June this year.
Media contact: Brad Watts
Executive Director, Communications
0487 922 176
This item is listed in the following categories: • 2018 media releases • Media releases